Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Capitol Hill, California Pose More Challenges For Supplement Industry In 2005

This article was originally published in The Tan Sheet

Executive Summary

The Vioxx recall and other prescription drug crises likely will lead to even more congressional scrutiny of dietary supplements, according to lobbyists working with the industry

You may also be interested in...



CRN Selects Former CHPA Exec Mister As Next President

Steven Mister brings extensive federal and state government affairs experience to his new post as president and CEO of the Council for Responsible Nutrition

CRN Selects Former CHPA Exec Mister As Next President

Steven Mister brings extensive federal and state government affairs experience to his new post as president and CEO of the Council for Responsible Nutrition

CRN Selects Former CHPA Exec Mister As Next President

Steven Mister brings extensive federal and state government affairs experience to his new post as president and CEO of the Council for Responsible Nutrition

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097447

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel